Keryx Reports Issuance of New US Patent for Auryxia(TM) Covering Orally Administrable

By: via Benzinga
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.